U.S. Markets closed

Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices

Victor Reklaitis
Drugmakers’ lobbying spending at 10-year high as Washington targets soaring prices

The spending by the industry’s main trade group and seven key drugmakers has climbed to a level not seen in a decade.